What Is the Ideal Tumor Regression Grading System in Rectal Cancer Patients after Preoperative Chemoradiotherapy? - Wikidata - awgldk - TriplyDB

What Is the Ideal Tumor Regression Grading System in Rectal Cancer Patients after Preoperative Chemoradiotherapy?

What Is the Ideal Tumor Regression Grading System in Rectal Cancer Patients after Preoperative Chemoradiotherapy?

http://www.wikidata.org/entity/Q37097565

about

Identification of protein clusters predictive of tumor response in rectal cancer patients receiving neoadjuvant chemo-radiotherapy.Discriminating cancer-related and cancer-unrelated chemoradiation-response genes for locally advanced rectal cancers.Do pathological variables have prognostic significance in rectal adenocarcinoma treated with neoadjuvant chemoradiotherapy and surgery?Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer.Histopathological factors predicting response to neoadjuvant therapy in gastric carcinoma.Histological grading based on poorly differentiated clusters is predictive of tumour response and clinical outcome in rectal carcinoma treated with neoadjuvant chemoradiotherapy.Tumor regression grading of gastrointestinal cancers after neoadjuvant therapy.A Modified Classification of Prognostic Factors Based on Pathological Stage and Tumor Regression Grade in Patients with Rectal Cancer Who Receive Preoperative Chemoradiotherapy.Prediction of lateral pelvic lymph node metastasis in patients with locally advanced rectal cancer with preoperative chemoradiotherapy: Focus on MR imaging findings.The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature.Impact of Tumor Regression Grade as a Major Prognostic Factor in Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy: A Proposal for a Modified Staging System

P2860

Q33709692-AFFF2FB7-72F1-434D-A062-2D915D4F9AD2 Q37414202-FDCDF8BD-8CED-4617-AC72-B65476E0A86A Q37672227-7E5EA4C4-796B-464A-BF88-C070CD8B8038 Q37729169-71BF87BE-2F7C-4EEB-8436-63673096E6AD Q48219339-21B984FD-908D-43D6-A409-5A8DD4F95FE2 Q48255590-6BA2F83E-A4A7-4178-8DA5-EA990B0CC812 Q48335407-331015C0-E422-47C2-9D51-82913D350F74 Q50317041-A9FB0FEE-A9B4-4A2E-868B-28E024F20E0B Q53074176-24A9F597-9532-4E7E-802B-3A86BD11116F Q53692873-015A0013-B42D-4FF0-B93F-032BC9AC9998 Q58758435-B129535B-D074-4D64-A9EE-E0D66ABDAF3B

P2860

What Is the Ideal Tumor Regression Grading System in Rectal Cancer Patients after Preoperative Chemoradiotherapy?

http://www.wikidata.org/entity/Q37097565

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 22 October 2015

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

What Is the Ideal Tumor Regres ...... reoperative Chemoradiotherapy?

@en

What Is the Ideal Tumor Regres ...... reoperative Chemoradiotherapy?

@nl

type

label

What Is the Ideal Tumor Regres ...... reoperative Chemoradiotherapy?

@en

What Is the Ideal Tumor Regres ...... reoperative Chemoradiotherapy?

@nl

prefLabel

What Is the Ideal Tumor Regres ...... reoperative Chemoradiotherapy?

@en

What Is the Ideal Tumor Regres ...... reoperative Chemoradiotherapy?

@nl

P1433

Q37097565-C0FFA5DF-6760-485E-8F94-E5265D1C2AAB

P1476

Q37097565-2FC8C441-BCA2-4156-B117-F8A1DB61682A

P2093

Q37097565-15A4229D-6895-4CAC-8FD1-CFAF90522F0E

Q37097565-1B5D5CCA-4B98-4622-929F-7657F8885B68

Q37097565-2A01A003-8A9F-4CD3-AFC7-B7D01DA16330

Q37097565-3D4E7C20-2C2C-47F1-A095-5C0611593951

Q37097565-516EBA10-3B17-4D6C-8DFA-98678B1BBFBB

Q37097565-69E54E40-A458-4541-B541-A947C496D7D4

Q37097565-B82BABB1-8FA4-4511-87D8-CBB4AA005B2B

Q37097565-DA584AAB-54C2-4D37-938C-BCD033DC24BD

Q37097565-E5EE9B75-303A-4808-89CC-468DECC490E2

Q37097565-FA9EDCEA-3AB9-4480-8A49-338CB7586A50

P2860

Q37097565-03562ED9-D76C-447D-A42C-83A4A7572D26

Q37097565-0495B4AF-4A24-450B-9257-0ECB245DD910

Q37097565-0E4A41FF-700F-4E92-8692-33A9882186B4

Q37097565-19015EC4-EA9E-4C41-A30D-B9F5E35151E1

Q37097565-595F6844-9803-4AAF-B2D0-C72A383E26B2

Q37097565-6222F72F-A782-4019-816B-FBDF7CDB6DD4

Q37097565-8FB72BE8-DA51-4E6F-A52E-DF67BFE75FAB

Q37097565-A6E2FFB9-F295-44AE-8D2E-0E119A3967A0

Q37097565-A84B5462-044D-4FFB-95B4-8B1AB77DA67B

Q37097565-B6231A7D-3852-4707-A543-020785FD384F

P304

Q37097565-34E6906A-6205-480C-B9C7-02FF96A52776

P31

Q37097565-4B5D1AE3-4A29-4585-8021-947FED3F0BB8

P356

Q37097565-99141337-BF2C-49D1-95B4-3404CDFCCD4E

P433

Q37097565-B83912D9-4543-4F40-A957-D1A6C581F9E3

P478

Q37097565-E5863EAB-E598-4895-AE98-D793EDBCECF0

P577

Q37097565-E7D8B01B-DE2B-4B6E-A93D-CF7FDBCA75CF

P5875

Q37097565-6F304E7A-1A68-4AD0-A74F-A8A4F32DF764

P698

Q37097565-B0A52106-6243-4E58-8C66-23BCAB6EE72C

P921

Q37097565-B7B0FA29-4182-43E2-A92D-8029A1BB5A31

P932

Q37097565-B2C642C8-076F-4ABC-BF28-02A247F45242

P356

P1433

Cancer Research and Treatment

P1476

What Is the Ideal Tumor Regres ...... reoperative Chemoradiotherapy?

@en

P2093

Ami Yu

http://www.w3.org/2001/XMLSchema#string

Byung-Ho Nam

http://www.w3.org/2001/XMLSchema#string

Dae Yong Kim

http://www.w3.org/2001/XMLSchema#string

Hee Jin Chang

http://www.w3.org/2001/XMLSchema#string

Jae Hwan Oh

http://www.w3.org/2001/XMLSchema#string

Ji Won Park

http://www.w3.org/2001/XMLSchema#string

Ji Yeon Baek

http://www.w3.org/2001/XMLSchema#string

Soo Hee Kim

http://www.w3.org/2001/XMLSchema#string

Sun Young Kim

http://www.w3.org/2001/XMLSchema#string

Sung Chan Park

http://www.w3.org/2001/XMLSchema#string

P2860

Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.

Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial.

Comparison of tumor regression grade systems for locally advanced rectal cancer after multimodality treatment.

Number of lymph nodes examined and prognosis among pathologically lymph node-negative patients after preoperative chemoradiation therapy for rectal adenocarcinoma

Adjuvant chemotherapy in rectal cancer: defining subgroups who may benefit after neoadjuvant chemoradiation and resection: a pooled analysis of 3,313 patients

The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer.

Impact of tumor response on survival after radiochemotherapy in locally advanced rectal carcinoma.

Prognosis of rectal carcinoma after multimodal treatment: ypTNM classification and tumor regression grading are essential.

Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.

International study group on rectal cancer regression grading: interobserver variability with commonly used regression grading systems.

P304

998-1009

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4143/CRT.2015.254

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283324076

http://www.w3.org/2001/XMLSchema#string

P698

26511803

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

4946373

http://www.w3.org/2001/XMLSchema#string